BioPorto A/S (CPH:BIOPOR)
Denmark
· Delayed Price · Currency is DKK 0.918
-0.023 (-2.44%)
Mar 6, 2026, 2:39 PM CET
BioPorto Employees
BioPorto had 48 employees as of December 31, 2024. The number of employees increased by 19 or 65.52% compared to the previous year.
Employees
48
Change (1Y)
19
Growth (1Y)
65.52%
Revenue / Employee
761.69K DKK
Profits / Employee
-1.81M DKK
Market Cap
465.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| ChemoMetec | 172 |
| Gubra | 275 |
| ViroGates | 7 |
| Scandinavian Medical Solutions | 29 |
BioPorto News
- 24 days ago - BioPorto A/S 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update - GlobeNewsWire
- 3 months ago - BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes - GlobeNewsWire
- 4 months ago - Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S - GlobeNewsWire
- 4 months ago - BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement - GlobeNewsWire
- 4 months ago - Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025 - GlobeNewsWire
- 5 months ago - BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented - GlobeNewsWire
- 7 months ago - BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. - GlobeNewsWire